Further reading:
Adhesive Pili in UTI Pathogenesis and Drug Development Spaulding CN, Hultgren SJ. Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens. 2016;5(1):30. Published 2016 Mar 15. doi:10.3390/pathogens5010030
D-Mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial Altarac, S. and Papeš, D. World J Urol. 2014 Feb;32(1):79-84. doi: 10.1007/s00345-013-1091-6. Epub 2013 Apr 30.
D-mannose: a promising support for acute urinary tract infections in women. A pilot study Domenici L, Monti M, Bracchi C, Giorgini M, Colagiovanni V, Muzii L, Benedetti Panici P. Eur Rev Med Pharmacol Sci. 2016 Jul;20(13):2920-5.
Oral D-mannose in recurrent urinary tract infections in women: a pilot study Porru, Daniele & Parmigiani, A. & Barletta, Davide & Choussos, D. & Bassi, Silvia & Miller, O. & Gardella, Barbara & Nappi, Rossella & Spinillo, A. & Rovereto, B.. (2013). European Urology Supplements. 12. e894-e895. 10.1016/S1569-9056(13)61373-1.
The efficacy of D-mannose in the prevention of recurrent urinary tract infections compared to long- term antibiotic therapy Stompro, Kristine. (2017).
Use of D‐mannose in prophylaxis of recurrent urinary tract infections (UTIs) in womenAltarac, S. and Papeš, D. (2014), Comment. BJU Int, 113: 9-10. doi:10.1111/bju.12492
References:
1. Foxman B. Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. N. Am. 2014;28:1–13. doi: 10.1016/j.idc.2013.09.003.
Griebling T.L. Urinary tract infection in women. In: Litwin M.S., Saigal C.S., editors. Urologic Diseases in Amerca. U.S. Government Printing Office; Washington, DC, USA: 2007. pp. 587–620.
Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: epidemiology, mechanims of infection and treatment options. Nat. Rev. Microbiol. 2015;13:269–284. doi: 10.1038/nrmicro3432.
2. Adhesive Pili in UTI Pathogenesis and Drug Development Caitlin N. Spaulding and Scott J. Hultgren Pathogens. 2016 Mar; 5(1): 30.